Join Us! Assembly Symposia
ATS Assemblies are offering virtual mini-symposia this fall. Join us for 90-minute sessions discussing:
- Newman Stephens Memorial Session: A Legacy of Science and Success
When: TODAY, 6 p.m. ET, Oct. 14, 2020
Register!
- Late Breaking Clinical Trials in Airway Diseases
When: 10 a.m. ET, Oct. 16, 2020
Register!
- Novel Causes of Environmental Asthma
When: 5 p.m. ET, Oct. 19, 2020
Register!
- What's New in Clinical and Translational Research In Pulmonary Hypertension: Lessons from the Best Abstracts
When: 12 p.m. ET, Oct. 21, 2020
Register
- Phenotypes, Endotypes, and Novel Therapies for SDB
When: 4 p.m. ET, Oct. 26, 2020
Register!
- Machine Learning and Data Driven Health Care Delivery
When: 4 p.m. ET, Oct. 27, 2020
Register!
- Tuberculosis Science Highlights
When: 2 p.m. ET, Oct. 28, 2020
Register!
- Expanding Our Horizons: Leading Research in Pulmonary Rehabilitation 2020
When: 10 a.m. ET, Nov. 2, 2020
Register!
Learn more about the full program!
ATS PAR Abstract Scholarship Presentations
Due to the cancellation of ATS 2020, this year’s ATS Public Advisory Roundtable activities were held virtually. Awardees presented a two-to-three minute overview of their science after a welcome by ATS Secretary-Treasurer M. Patricia Rivera, MD, ATSF; PAR chair-elect Michele Manion; and ATS Assembly leadership Jay Kolls, MD, and MeiLan Han, MD, MS.
Upcoming Events
Industry Innovations Webinars
Join us for “A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma.”
When: 6:30 p.m. ET, Oct. 15, 2020
Register now!
Sponsored by Regeneron Sanofi Genzyme.
Join “The Role of Eosinophils and Their Potential Heterogeneity in Airway Disease.”
When: 6:30 ET, Oct. 29, 2020
Register now!
Sponsored by GSK.
By registering for Industry Innovations webinars, you agree to share your information with the sponsor.
CME Opportunity!
Learn what’s new in nontuberculous mycobacterial lung disease from a panel of experts. Download slides, and complete the video modules to earn Continuing Medical Education credits. Full CME information is available on the site.
Twitter Chat
Join Bram Rochwerg, MD (@Bram_Rochwerg) and Jeremy E. Orr, MD (@jeremyeorr) to chat about “Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease."
When: 1 p.m. ET, Oct. 21, 2020
Where: Twitter, using #ATSchat
Lack of Knowledge Is One Barrier to Prone Positioning in Severe ARDS Caused by COVID-19
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.
In “Improving Prone Positioning for Severe ARDS during the COVID-19 Pandemic: An Implementation Mapping Approach,” Meeta Prasad Kerlin, MD, MSCE, an associate professor of medicine in the Perelman School of Medicine at the University of Pennsylvania, and co-authors conducted a multifaceted study to help determine why prone positioning is rarely used as an initial therapeutic strategy for patients with ARDS, as well as ways to address these potential barriers.
New Patient Information Resources
View and print the new Patient Information Resource, “COVID-19 Infection versus Influenza (Flu) and Other Respiratory Illnesses” to help your patients navigate flu season amid the COVID-19 pandemic. The ATS has also recently created a new section devoted to oxygen therapy, and our ICU guide for patients and families, “Managing the Intensive Care Unit Experience,” is now available in three languages, and in an audio version.
